Moderna says its experimental mRNA influenza vaccine, mRNA-1010, showed more than 30% greater relative vaccine efficacy ...

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) Feb ...

Moderna is a well-known biotech company from its pandemic success. Here's what investors should know about its growth story now.

FDA issues a Refusal to File letter to Moderna (NasdaqGS:MRNA) for its influenza vaccine candidate mRNA-1010. The decision ...

At issue with Moderna's mRNA flu shot is communication from CBER to Moderna suggesting that the company’s vaccine be compared ...

The FDA declined to review Moderna's mRNA influenza vaccine due to inadequate clinical trial comparators for older adults.

The Food and Drug Administration has refused to review an application from the biotech company Moderna to approve its ...

During the first year of the Trump administration, signs of an anti-mRNA slant within the FDA and the Department of Health and Human Services (HHS) became more and more evident. | The FDA specifically ...

(THE CONVERSATION) The Food and Drug Administration’s decision, made public on Feb. 10, 2026, to not review an application to approve Moderna’s proposed mRNA-based flu vaccine set off a firestorm of ...

The US Food and Drug Administration's (FDA’s) Center for Biologics Evaluation and Research (CBER) is refusing to review Moderna’s application for approval of a new flu vaccine. The decision comes ...

President Sheinbaum announced on Monday the signing of an agreement between Mexico's Health Ministry, state-owned medical ...

As the U.S. backpedals on its mRNA investment, Mexico is embracing the technology through a new manufacturing pact with ...